+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID07487948

Pilot Study to Evaluate Safety and Biomarker Effects of Twice-Daily Topical Delgocitinib 2% Cream in Adults with Central Centrifugal Cicatricial Alopecia or Lichen Planopilaris

Led by Icahn School of Medicine at Mount Sinai · Updated on 2026-07-10

30

Participants Needed

1

Research Sites

38 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying the safety, tolerability, and biomarker effects of a twice-daily topical cream called delgocitinib 2% in adults who have either lichen planopilaris LPP or central centrifugal cicatricial alopecia CCCA. These are conditions that cause hair loss and scalp inflammation. The study is a Phase 2 clinical trial enrolling about 30 participants, split evenly between those with CCCA and LPP, taking place at the Icahn School of Medicine at Mount Sinai. Participants will apply delgocitinib cream to the affected scalp areas twice daily for 48 weeks. The study includes two groups based on diagnosis one with CCCA and one with LPP. Researchers will assess changes in various immune and inflammatory markers in the scalp, such as IFNB3, CCL5, CXCL9, and CXCL10, during treatment. The study also monitors clinical signs of hair loss and scalp health using established scales and molecular analyses of scalp biopsies. Throughout the trial, participants will undergo regular evaluations including scalp biopsies, hair counts, quality of life questionnaires, and assessments of itch severity. These measures will be collected at baseline and multiple time points up to 48 weeks to monitor the effects of the treatment. Safety and tolerability will be closely observed. The total participation time is approximately 48 weeks, during which researchers will collect data to better understand delgocitinibs impact on these scalp conditions and associated biomarkers.

CONDITIONS

Brief Title

Safety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Alopecia and Lichen Planopilaris

Research Team

G

Giselle Singer

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here